Single Dosing of Zoledronic Acid in Cancer Therapy Induced Bone Loss (CTIBL)
Clinical trial NCT00712985 · COMPLETED
Trial details
- NCT number
- NCT00712985
- Sponsor
- Milton S. Hershey Medical Center
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-01
- Primary completion
- 2011-03-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.